Leuprolide Completed Phase 2 Trials for Prostatic Neoplasms Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00170157MDX-010 for Advanced Prostate Cancer
NCT00817739Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c